Dimensional Fund Advisors LP Myriad Genetics Inc Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,213,210 shares of MYGN stock, worth $9.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,213,210

Previous 2,272,355 2.6%

Holding current value

$9.87 Million

Previous $31.2 Million 36.99%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$8.87 - $14.98 $524,616 - $885,992	-59,145 Reduced 2.6%	2,213,210 $19.6 Million
Q4 2024 Feb 13, 2025	SELL	$13.17 - $27.03 $1.99 Million - $4.08 Million	-151,122 Reduced 6.24%	2,272,355 $31.2 Million
Q3 2024 Nov 07, 2024	SELL	$23.97 - $28.6 $8.47 Million - $10.1 Million	-353,482 Reduced 12.73%	2,423,477 $66.3 Million
Q2 2024 Aug 09, 2024	BUY	$17.98 - $25.47 $1.36 Million - $1.92 Million	75,445 Added 2.79%	2,776,959 $67.9 Million
Q1 2024 May 10, 2024	BUY	$17.59 - $23.59 $362,283 - $485,859	20,596 Added 0.77%	2,701,514 $57.6 Million
Q4 2023 Feb 07, 2024	BUY	$13.91 - $21.32 $1.24 Million - $1.9 Million	89,330 Added 3.45%	2,680,918 $51.3 Million
Q3 2023 Nov 09, 2023	SELL	$15.99 - $23.22 $1.31 Million - $1.9 Million	-81,883 Reduced 3.06%	2,591,588 $41.6 Million
Q2 2023 Aug 09, 2023	SELL	$17.56 - $23.76 $894,242 - $1.21 Million	-50,925 Reduced 1.87%	2,673,471 $62 Million
Q1 2023 May 12, 2023	BUY	$15.26 - $23.75 $1.38 Million - $2.15 Million	90,532 Added 3.44%	2,724,396 $63.3 Million
Q4 2022 Feb 09, 2023	BUY	$14.51 - $20.99 $2.92 Million - $4.23 Million	201,414 Added 8.28%	2,633,864 $38.2 Million
Q3 2022 Nov 10, 2022	SELL	$18.21 - $27.88 $1.98 Million - $3.03 Million	-108,757 Reduced 4.28%	2,432,450 $46.4 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $324,673 - $510,793	-19,737 Reduced 0.77%	2,541,207 $46.2 Million
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $1.7 Million - $2.1 Million	-74,859 Reduced 2.84%	2,560,944 $64.5 Million
Q4 2021 Feb 09, 2022	SELL	$24.13 - $32.63 $1.22 Million - $1.65 Million	-50,573 Reduced 1.88%	2,635,803 $72.7 Million
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $2.47 Million - $3.02 Million	-82,328 Reduced 2.97%	2,686,376 $86.7 Million
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $960,376 - $1.23 Million	37,825 Added 1.39%	2,768,704 $84.7 Million
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $620,667 - $984,592	-31,158 Reduced 1.13%	2,730,879 $82.9 Million
Q4 2020 Feb 25, 2021	BUY	$12.16 - $19.77 $33.6 Million - $54.6 Million	2,762,037 New	2,762,037 $54.6 Million

Others Institutions Holding MYGN

# of Institutions

240

Shares Held

95.3M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $360M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Myriad Genetics Inc Transaction History